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ABSTRACT
Mitochondrial DNA maintenance and segregation
are dependent on the actin cytoskeleton in
budding yeast. We found two cytoskeletal proteins
among six proteins tightly associated with rat liver
mitochondrial DNA: non-muscle myosin heavy chain
IIA and b-actin. In human cells, transient gene
silencing of MYH9 (encoding non-muscle myosin
heavy chain IIA), or the closely related MYH10
gene (encoding non-muscle myosin heavy chain
IIB), altered the topology and increased the copy
number of mitochondrial DNA; and the latter effect
was enhanced when both genes were targeted sim-
ultaneously. In contrast, genetic ablation of
non-muscle myosin IIB was associated with a 60%
decrease in mitochondrial DNA copy number in
mouse embryonic fibroblasts, compared to control
cells. Gene silencing of b-actin also affected mito-
chondrial DNA copy number and organization.
Protease-protection experiments and iodixanol
gradient analysis suggest some b-actin and
non-muscle myosin heavy chain IIA reside within
human mitochondria and confirm that they are
associated with mitochondrial DNA. Collectively,
these results strongly implicate the actomyosin
cytoskeleton in mammalian mitochondrial DNA
maintenance.
INTRODUCTION
A complex protein apparatus is required to ensure the main-
tenance, reproduction and transmission of mitochondrial
DNA (mtDNA) (1–3). In budding yeast the actin cyto-
skeleton plays important roles in the transmission of
mitochondria and mtDNA to daughter cells (1). In
mammals, studies of axonal mitochondrial transport
have linked kinesin motors and microtubule ﬁlaments to
the rapid transport of mitochondria over long distances,
whereas mitochondrial movement over short distances is
dependent on an actin-based motor (4). Hollenbeck and
Saxton also suggest that members of the myosin families I,
II, V and VI could act as molecular motors for mitochon-
drial movement along actin cables. However, the only
family member shown to be associated with mitochondria
hitherto is Myo19 (5).
Mitochondrial DNA segregation and transmission in
budding yeast is an actin-dependent process (6).
Mammalian mtDNA maintains strong contacts with the
cytoskeleton (7), yet the speciﬁc proteins involved have
not been deﬁned. There have been hints that b-actin
might be linked to mammalian mtDNA, it was
immunoprecipitated by an antibody to the mtDNA
binding protein TFAM (8), it co-puriﬁed with tagged
MTERF2 (9) and b-actin was among proteins co-
sedimenting with a fraction of mtDNA from HeLa cells
(10). However, b-actin is a highly abundant cellular
protein and a frequent contaminant in protein puriﬁcation
experiments suggesting that these results should be treated
with caution. Indeed Pellegrini et al. (2009) quite reason-
ably assumed b-actin was present as a contaminant in
their MTERF2 preparations. Here we found b-actin and
non-muscle myosin heavy chain IIA associated with
mtDNA after stringent washing of enriched mitochondrial
nucleoprotein, leading us to implement a series of bio-
chemical and genetic tests. The results support a role for
b-actin, and the actin binding proteins non-muscle myosin
IIA and IIB, in mammalian mtDNA maintenance.
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Isolation of mitochondrial nucleoprotein complexes
Sucrose-gradient puriﬁed rat liver mitochondria were
prepared as previously (11,12). Next, 6–12mg
mitochondria were disrupted by suspension in lysis
buffer: 10mM HEPES–NaOH, pH 7.6, 0.2mM PMSF,
1mM EDTA, 1mM DTT and 0.4% n-Dodecyl-b-D-
maltopyranoside (DDM), at 4 C and centrifuged at
1000 gmax for 10min. The supernatant (s/n 1) was
re-centrifuged at 30000gmax for 30min. Next the pellet
(pellet 2) was homogenized vigorously with 10 strokes
every 10min at 4 C for 2h in 0.5ml of 900mM NaCl,
50mM HEPES, 12.5mM EDTA, 5  Complete
EDTA-free Protease Inhibitor Cocktail (Roche), 5mM
DTT. The homogenate was divided in two and centrifuged
at 30000gmax for 1h. DNA was extracted from one of the
ﬁnal pellets (pellet 3), whereas the other was mixed with
loading buffer containing 2% SDS and the proteins
fractionated by PAGE; individual proteins visible after
staining with Coomassie blue were digested into peptides
‘in-gel’ with sequencing grade trypsin (Roche), in 20mM
Tris–HCl, pH 8.0, 5mM CaCl2 overnight at 37 C. The
ensuing peptide mixtures were analysed by a
MALDI-TOF-TOF mass spectrometer (4700 Proteomics
Analyzer, Applied Biosystems) in MS (peptide ﬁngerprint-
ing) and MS-MS (peptide sequencing) modes. Proteins
were identiﬁed by MASCOT search with two modes:
Peptide Mass Fingerprint or MS/MS data were
compared with NCBInr (all entries or Rattus) protein
sequence databases. Identiﬁed proteins had a Mascot
score greater than a database-generated 95% conﬁdence
score for peptide mass ﬁngerprinting data, and/or two or
more peptides identiﬁed from peptide sequencing data.
Mitochondrial import assay
35S-methionine labelled proteins were generated from
ampliﬁed cDNAs using a TnT Quick Coupled
Transcription-/Translation system
TM
(Promega). Labelled
proteins were incubated with rat liver mitochondria
puriﬁed by differential centrifugation for 120min at
37 C (13) with the addition of supernatant from the
second centrifugation step, as this was found to facilitate
b-actin import into mitochondria. Products were
fractionated by SDS–PAGE. Additions were 50mg/ml
trypsin, to digest protein outside mitochondria; FCCP
(carbonylcyanide-p-triﬂuoromethoxyphenylhydrazone) to
dissipate the mitochondrial membrane potential; 0.1%
Triton-X100 to lyse the mitochondria.
Cell culture and siRNA
HOS and HEK cells were grown in DMEM with 10%
fetal bovine serum. For short interfering RNAs
(siRNA), cells growing on 6-well plates at 25–30% conﬂu-
ent were transfected with 5–10nM double stranded RNA
and 3ml of Lipofectamine2000 (Invitrogen). Where
indicated cells were transfected a second time, at 72h,
and examined by confocal microscopy at 144h, or lysed
for total RNA or DNA extraction. The siRNA targeting
b-actin was a siLentMer validated RNA (Bio-Rad Cat #
179-0204). Double-stranded RNAs targeting, MYH9 or
MYH10, from iGENE (Tokyo, Japan) were as follows:
MYH9-2806: 50-GCGGAGAAGAAGAAGAUGCAGC
AGAAG-30,3 0-UACGCCUCUUCUUCUUCUACGUC
GUC U-50; MYH9-3064: 50-AAGAACAAGCAUGAGG
-CAAUGAUCAAG-30,3 0-UAUUCUUGUUC GUACU
CCGUUACUAGU-50; MYH10-2783: 50-AGUCUAGG
GUUGAAGAAGAAGAAGAAG-30,3 0-UAUCAGAU
CCCAACUUCUUCUUCUUCU-50; MYH10-2263: 50-G
AAUUGGACCCAAA CUUGUACAGAAAG-30,3 0-UA
CUUAACCUGGGU-UUGAACAUGUCUU-50.
Quantitative PCR of MYH9 mRNA was performed using
primers 50-CACTGAGACGGCCGATGC-30 and 50-GTC
CCCGCGCCTGAG-30, with probe 50-ATGAACCGCG
AAGTCAGCTCCCTAAAGAAC-30; and for MYH10,
primers 50-CCTGCGAACCCTCCTGGT-30 and 50-TTT
TATCTGTGGC TTTAGGGAACC-30, with probe 50-T
ACTGGCCCTTTTGGATG-30. Probes had a FAM
ﬂuorophore and a TAMRA quencher attached
(Sigma-Genosys). Mitochondrial DNA copy number
was estimated by comparing the abundance of the mito-
chondrial cytochrome b gene to that of the nuclear
APP gene, as described (14). Twinkle siRNA was as pre-
viously described (14).
Confocal microscopy
HOS cells were washed and live-stained with 3ml
PicoGreen reagent (Invitrogen) and 100nM of
mitotracker orange (Invitrogen) as described (14,15).
The excitation/emission wavelengths for PicoGreen and
mitotracker orange were 502/523nm and 554/576nm, re-
spectively. DNA, NM-IIB, and b-actin were labelled in
ﬁxed cells using a 1:200 mouse anti-DNA antibody
(PROGEN Biotechnik), 1:50 anti-rabbit NM-IIB
antibody and 1:3000 anti-b-actin (SIGMA). Secondary
antibodies were 1:1000 anti-mouse Alexa Fluor 488
(Invitrogen) for DNA and b-actin, and 1:5000 anti-rabbit
Alexa Fluor 488 (Invitrogen) for NM-IIB. A
Radiance2000 (BIORAD) or a Zeiss LSM 510 confocal
microscopy system was used for cell imaging. Images were
acquired with a 60  or 63  oil immersion objective and
processed in Adobe Photoshop. Nucleoid number and
area were quantiﬁed using Andor iQ software.
DNA and protein analysis
MEF cells and mitochondria were lysed with extraction
buffer (EB) containing 75mM NaCl, 50mM EDTA,
20mM HEPES-NaOH (pH 7.8) and 0.5% SDS. The
lysate was extracted successively with phenol and chloro-
form/isoamyl alcohol (24:1), and DNA resuspended in
20mM HEPES pH 7.25. Three micrograms of total
cellular DNA (three separate isolates for both cell types)
was digested with BlpI, and the fragments resolved by
agarose gel electrophoresis and visualized by Southern hy-
bridization using radiolabelled probes directed against
mouse mtDNA (nucleotides 14866–15331) and nuclear
DNA (18S rDNA). Signal quantiﬁcation relied on a
Molecular Imager FX phosphorimager (Typhoon
TM,G E
Healthcare).
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NM-IIA 1:2000 (Sigma), b-actin 1:15000 (Sigma), the
intermediate ﬁlament vimentin, or VIM 1:500 (Abcam),
the microtubule protein b-tubulin (Sigma), the mitochon-
drial outer membrane protein TOM20 (Santa Cruz), the
intermembrane space protein cytochrome c, or CYC
1:200, the inner mitochondrial membrane protein cyto-
chrome c oxidase subunit II, or COX2 (Abcam), the mito-
chondrial chaperone HSP60 (Abcam), mitochondrial
transcription factor A, or TFAm 1:40000, ATPase
family AAA domain-containing protein 3, or ATAD3
1:50000, and cytosolic glyceraldehyde dehydrogenase, or
GAPDH 1:5000 (Abcam). Secondary antibodies were
anti-rabbit and anti-mouse HRP 1:1000 (Promega).
These antibodies were used to probe membranes contain-
ing proteins separated on NuPAGE 4–12% SDS–PAGE
(Invitrogen).
Sucrose-gradient puriﬁed mitochondria from HEK cells
(2mg/ml) were suspended in 20mM HEPES pH 7.8,
2mM EDTA, 210mM mannitol, 70mM sucrose and
treated with or without 100mg/ml of trypsin at room tem-
perature for 30min. After washing and pelleting
mitochondria three times, the organelles were lysed with
0.4% DDM and centrifuged for 10min at 1000gmax; the
supernatant was loaded on a 20–42.5% iodixanol gradient
(20mM HEPES pH 7.8, 1mM EDTA, 50mM NaCl,
2mM DTT, 0.05% DDM with protease inhibitor) and
centrifuged at 100000gmax for 14h. Nucleic acid was ex-
tracted from a portion of each fraction of the gradient and
after Southern blotting, hybridized to a radiolabelled
probe to estimate the level of mtDNA, the remainder of
each fraction was analysed by immunoblotting after SDS–
PAGE.
RESULTS AND DISCUSSION
In a previous study, we isolated mitochondrial nucleopro-
tein complexes (nucleoids) from rat liver mitochondria
using a generic DNA binding protein from Escherichia
coli, HU (11). Here crude mitochondrial nucleoids were
rigorously washed in a 900mM NaCl solution to remove
all but the most tightly associated proteins from the
mtDNA. TFAM, for instance, dissociates from mtDNA
under these conditions (Supplementary Figure S1A). Mass
spectrometry repeatedly identiﬁed only six proteins in the
ﬁnal pellet that was highly enriched for mtDNA (Figure 1
and Table 1). Two mitochondrial proteins, ATAD3 and
NIPSNAP1, were also present in our previous mitochon-
drial nucleoprotein preparations (Figure 1D) (11). The
fact that ATAD3 and NIPSNAP1 co-purify with
mtDNA using two different protocols strengthens their
designation as nucleoid proteins. Another of the proteins
present in the high-salt treated mtDNA preparations was
prohibitin. Prohibitin is a well-established mitochondrial
membrane protein with roles in protein processing, cristae
formation and mitochondrial morphogenesis (16).
Although prohibitin was not among the handful of
proteins associated with HU-afﬁnity puriﬁed mtDNA
(11), it was present in mitochondrial nucleoprotein
preparations of Xenopus oocytes and cultured human
cells (10,17). Moreover, as with ATAD3 gene
knockdown (11), prohibitin gene-silencing produces a
marked decrease in PicoGreen staining of mitochondrial
nucleoids (18). Prohibitin is important for mtDNA stabil-
ity in yeasts and Langer and colleagues propose that the
ring-like prohibitin complex can form a scaffold
contributing to the integrity of the mitochondrial inner
membrane (19). This would ﬁt well with the idea of it
stabilizing mtDNA, while permitting it to have other func-
tions, such as its well-documented roles in protein process-
ing (16). The presence of prohibitin in mtDNA-enriched
material reported here adds to the growing body of
evidence suggesting it contributes to mtDNA maintenance
in mammals, as well as yeasts. Although uricase was the
most abundant protein sedimenting with mitochondrial
nucleoprotein (Figure 1C), it was almost certainly a con-
taminant, as it forms large crystals, which happen to
sediment at the centrifugal forces used to harvest mito-
chondrial nucleoprotein complexes, and it is not expressed
in humans (20).
Mitochondrial DNA and cytoskeletal factors
The remaining two candidate nucleoid proteins were
b-actin and non-muscle myosin heavy chain IIA
(NM-IIA), which form microﬁlaments that are a key com-
ponent of the cytoskeleton. Immunoblotting of samples
derived from rat liver mitochondria conﬁrmed that,
while only a small proportion of total cellular b-actin
co-puriﬁes with mitochondria (Figure 1E),
mitochondrial-associated b-actin is enriched in 1000gmax
supernatants together with mitochondrial DNA polymer-
ase g (Figure 1E), and mtDNA (Figure 1A). NM-IIA and
its close relative NM-IIB are class II non-muscle myosin
motor proteins, which are known to play important roles
in diverse cellular functions including cytokinesis, mor-
phogenesis and cell polarity (21). NM-IIA and NM-IIB
share 77% identity at the amino acid level, and the ability
of NM-IIA to complement some of the deﬁciencies
associated with ablation of NM-IIB suggests considerable
functional overlap between the two proteins (22).
Inspection of the mass spectrometry data revealed that
some masses were unique to NM-IIA, whereas no
unique NM-IIB peptides were detected, suggesting that
NM-IIB was absent from the rat liver mitochondrial nu-
cleoprotein preparations. Of the two proteins, NM-IIA is
relatively more abundant in rodent liver than several other
tissues (23), and so the amount of NM-IIB in our prepar-
ations may have been below the limit of detection.
Alternatively, NM-IIB may not bind as tightly to mito-
chondrial nucleoids as NM-IIA, and so may have
dissociated during the high-salt isolation procedure
(‘Materials and Methods’ section).
As a further test of the association of NM-IIA and
b-actin with mtDNA, TFAM with a Streptactin tag was
expressed in HEK.293T cells and the tagged protein re-
covered by afﬁnity puriﬁcation, after mitochondrial puri-
ﬁcation and lysis. Immunoblotting of NM-IIA, b-actin
and SSBP1 in fractions sampled during the puriﬁcation
procedure indicated that all three proteins were captured
together with mtDNA (Supplementary Figure S1B).
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Transfection of human osteosarcoma (HOS) cells with
siRNA capable of decreasing MYH9 or MYH10 expres-
sion to 10–15% of control values (Supplementary Figure
S2A) produced two mtDNA-related phenotypes. There
was a pronounced decrease in PicoGreen staining of
mitochondrial nucleoids after MYH9 or MYH10 siRNA
treatment (Figure 2A and Supplementary Figure S2B).
PicoGreen staining of DNA depends largely on the ar-
rangement of DNA: supercoiled DNA produces a lower
signal per unit mass of DNA than relaxed circles.
Previously we documented a marked decrease
in PicoGreen staining associated with a modest decrease
in mtDNA copy number, after ATAD3 siRNA
Figure 1. Enrichment of mitochondrial nucleoprotein via differential centrifugation and high-salt treatment. (A) DNA associated with
sucrose-gradient puriﬁed rat liver mitochondria (mt) was analysed by agarose gel electrophoresis, before (lane 1) and after detergent lysis and
1000gmax centrifugation for 10minutes (lanes 2 and 3). The ﬁrst supernatant (s/n1) was centrifuged at 30000gmax for 30min to sediment the bulk of
the mtDNA and the pellet (2) was subjected to stringent washing in 900mM NaCl, before being re-centrifuged (30000gmax, 60min). (B) DNAs
extracted from a fraction of pellet 3 and supernatant 3 were analysed by ethidium bromide staining (lanes 1 and 2) or by Southern hybridization to a
probe corresponding to the large non-coding region of rat mtDNA (lanes 3 and 4, the two lanes shown were run on the same gel but in lanes that
were not adjacent). (C) proteins separated by 12–22% SDS–PAGE and stained with Coomassie blue; lane 1—molecular mass markers; lane 2—pro-
teins associated with the third pellet which contained the bulk of the intact mtDNA; lane 3—total mitochondrial lysate. Six proteins were identiﬁed
by mass spectrometry with an error tolerance <70ppm (Table 1); n=two independent experiments. (D) a Venn diagram showing the sets of
candidate nucleoid proteins identiﬁed in this (high-salt puriﬁcation) and an earlier study based on afﬁnity capture of mtDNA with a generic
DNA binding protein, HU (11), see main text for details. (E) immunoblotting of the ﬁrst 1000gmax supernatant (s/n1), mitochondria (mt) and
rat liver homogenate (hmg) with antibodies to POLG1 and b-actin. Trypsin treatments (+), which preceded lysis of mitochondria, were 50mg/ml for
30min at 37 C. (F) Preliminary model of the organization of mtDNA with candidate nucleoid proteins. OMM—outer mitochondrial membrane,
IMM—inner mitochondrial membrane. NM-IIA—non-muscle myosin heavy chain IIA, ATAD3—ATPase family AAA domain-containing protein
3A, Nipsnap1: 4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homologue 1.
Nucleic Acids Research, 2011,Vol.39, No. 12 5101treatment (11). In the case of MYH9 or MYH10
gene-silencing, the decrease in PicoGreen staining of mito-
chondrial nucleoids was accompanied by a 1.5-fold
increase in mtDNA copy number, based on quantitative
(Q-) PCR (Figure 2B). Moreover, the increase in copy
number reached 3.3 times that of controls when siRNAs
targeting MYH9 and MYH10 were employed together
(Figure 2B). Thus, NM-IIA and NM-IIB each contribute
to mtDNA homeostasis.
Mitochondrial DNA depletion in mouse embryonic
ﬁbroblasts lacking NM-IIB
MYH10 has been ablated in mice (24), enabling us to de-
termine the contribution of NM-IIB to mtDNA mainten-
ance. Based on Southern hybridization mtDNA copy
number was reduced to 38% of control values in
MYH10
 /  mouse embryonic ﬁbroblasts (Figure 3A).
Q-PCR also indicated a substantial decrease in mtDNA
copy number in cells lacking NM-IIB (Supplementary
Figure S2C), whereas the abundance of an outer and an
inner mitochondrial membrane protein were unaffected by
the loss of MYH10 (Supplementary Figure S3A), suggest-
ing there was no generalized decrease in mitochondria in
MYH10
 /  cells. Therefore, loss of MYH10 causes
mtDNA depletion.
The absence of NM-IIB was associated with changes in
mitochondrial morphology, as well as mtDNA depletion:
confocal microscopy revealed extensive fragmentation of
the mitochondrial network in many more MYH10
 /  cells,
than control cells (Figure 3B, 3C-v and 3C-xi). There was
also a signiﬁcant increase in the number of cells in which
mitochondria were not as widely distributed as in control
cells, but had a more central location close to the nucleus;
these were designated as having ‘contracted’ mitochondria
(3C-vi and 3C-xii) (see also b-actin siRNA below).
Comparison of MYH10
+/+ and MYH10
 /  MEFs
revealed no signiﬁcant difference in the number
(P=0.51) or size (P=0.91) of nucleoids in cells with
normal mitochondrial morphology. MYH10
 /  cells with
‘contracted’ mitochondria had fewer nucleoids, whereas
those cells with a fragmented mitochondrial network had
smaller nucleoids, yet similar numbers of nucleoids to
control cells (Figure 3D). Hence, mitochondrial fragmen-
tation in MYH10
 /  cells was associated with a reduction
in the number of copies of mtDNA per nucleoid. None of
these changes had an appreciable effect on the growth rate
of the MEFs (Supplementary Figure S3B).
The opposite effects of a shortage of NM-IIB on
mtDNA copy number of HOS cells (Figure 2B) and
MEFs (Figure 3A) might reﬂect differences in mitochon-
drial nucleoid composition between the two cell types. The
ability of MEFs to tolerate the loss of MYH10 implies
reprogramming of gene expression to adapt to the loss
of the gene. Monitoring mtDNA in a conditional
knockout mouse could clarify whether or not an
increase in mtDNA level is the typical initial response to
a shortage of NM-IIB (or NM-IIA).
b-actin siRNA perturbs mtDNA mass, organization and
mitochondrial morphology
b-actin siRNA produced a 40% decrease in mtDNA copy
number, 48–96h after transfection of HOS cells, based on
Q-PCR analysis (Figure 4A). Thereafter copy number rose
and 144h after transfection mtDNA copy number
exceeded the level of control cells (Figure 4A), despite
the fact that b-actin expression remained low
(Figure 4B, Supplementary Figure S4A). b-actin siRNA
was also associated with contraction of mitochondria
away from the cell periphery, and with mitochondrial
fragmentation (Figure 4B and C). Fragmentation of the
Table 1. Proteins co-purifying with rat liver mtDNA after differential centrifugation of mitochondrial lysates and high salt treatment, identiﬁed
by MALDI-peptide mass ﬁngerprinting
Band Protein Accession no. Molecular Mass (kDa) MALDI-TOF MS Data
a
NCBI gi accession No. Observed
b Predicted Peptide matches
c Sequence coverage % Mascot Score
d
a1 NM-IIA
e 6981236 234.9 226 23/30 16 150/76
a2 193.5 226 6/9 4 40/58
b ATAD3A
f 77415397 59.1 66 9/17 22 86/78
c b-actin 71620 48.3 41 10/12 35 151/58
d Uricase 20127395 34.9 34 12/23 37 131/76
e Prohibitin 62664759 33.8 29 8/27 42 86/58
f Nipsnap1
g 34879019 30.5 33 7/19 23 59/76
h
Data are for tryptic peptides. Number of entries of NCBInr database: 3023944.
aDerived from proteins enriched from 3–6mg lots of mitochondria.
bObserved masses in kiloDaltons (kDa) were based on protein standards. The equation used was y=0.133x
4 3.8757x
3+39.963x
2 – 176.58x+333.81,
R
2=0.976.
cnumber of mass matches/total masses searched.
dmass tolerance parameter used: 70ppm.
eNM-IIA: Non-muscle myosin heavy chain IIA; NMMHC II-a; NMMHC-IIA; MYH9, Myosin non-muscle heavy chain 9; Myosin heavy chain,
non-muscle IIA; Cellular myosin heavy chain, type A.
fATAD3: ATPase family AAA domain-containing protein 3A (ATAD3A) in rat; ATPase family AAA domain-containing protein 3B (ATAD3B) in
human; AAA-ATPase TOB3; TOB3.
gNipsnap1: 4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homologue 1.
hfour peptides analysed by tandem MS matched Nipsnap1.
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silencing, whereas contracted mitochondria were most
prevalent 48h after transfection, and declined in number
thereafter (Figure 4C and Supplementary Figure S4B).
Those cells deﬁned as having contracted mitochondria
had larger and fewer nucleoids than controls (P<0.001)
(Figure 4D), while nucleoids were also fewer in number in
cells with fragmented mitochondria, the difference was less
marked (Figure 4D). Thus, the fragmentation of
mitochondria may relieve the constraint on mtDNA rep-
lication imposed by the paucity of b-actin, and thereby
explain the increase in mtDNA copy number observed
between the 96 and 144h time points (Figure 4A). The
increase in mtDNA copy number between 96 and 144h
of b-actin siRNA was substantial (2-fold) and highly sig-
niﬁcant (P<0.001). Although there was a modest increase
in b-actin 144h after the ﬁrst siRNA transfection
compared to earlier time points, the level of the protein
remained well below that of control cells (Figure 4B-iii,
Supplementary Figure S4A) and so the level of b-actin was
not directly proportional to the number of mtDNA
molecules per cell.
A fraction of b-actin and NM-IIA is located inside
human mitochondria
The majority of b-actin and NM-IIA reside in the cyto-
plasm outside mitochondria, and so the initial presump-
tion was that b-actin and NM-IIA were linked to mtDNA
via adaptor proteins that bridge the mitochondrial mem-
branes (Figure 1F). Mitochondrial nucleoprotein
complexes can be resolved on iodixanol gradients, and
analysed by Southern and immunoblotting, after organelle
lysis (25). Here this approach, applied to HEK cell derived
mitochondria, demonstrated that some b-actin and
NM-IIA co-fractionate with mtDNA and TFAM,
whereas the majority of mitochondrial proteins resolve
near the top of the gradient, e.g. COX2 and HSP60
(Figure 5A-i and Supplementary Figure S5). A substantial
amount of the b-actin and NM-IIA associated with
human mitochondria survived when isolated
mitochondria were treated with trypsin, prior to lysis
and iodixanol gradient fractionation (Figure 5A-ii). In
contrast, the mitochondrial outer membrane protein
TOM20 and the cytoskeletal proteins b-tubulin and
vimentin were completely degraded by trypsin
Figure 2. MHY9 siRNA affects mtDNA topology and copy number. (A) HOS cells transfected twice with dsRNA MYH9-2806 or MYH10-2783
were stained with PicoGreen (green) and mitotracker (red) and examined by confocal microscopy at 1200  and 600  magniﬁcation; t=144h.
(B) MtDNA copy number was estimated via Q-PCR of HOS cell DNA after 144h of MYH9 and/or MYH10 siRNA. Because initial results
suggested an increase in mtDNA copy number, Twinkle siRNA was carried out in parallel for 72h, as this was known to cause mtDNA depletion
(14). n=4 experiments for MYH9 and MYH10 siRNA and n=2 for Twinkle. Errors are ±1 standard deviation from the mean.
Nucleic Acids Research, 2011,Vol.39, No. 12 5103(Figure 5A-ii). Furthermore, the surviving b-actin and
NM-IIA was concentrated in the same fractions of the
iodixanol gradients as the mtDNA, corroborating the
initial ﬁnding that both these proteins are associated
with mtDNA (Figure 1 and Supplementary Figure S1B).
ATAD3 also co-fractionated with TFAM and mtDNA
(Figure 5A).
Next human b-actin and the closely related b-actin-like
2 were synthesised in vitro using reticulocyte lysates and
incubated with isolated rat liver mitochondria. A small
amount (6%) of b-actin, but not its close relative
b-actin-like 2, survived trypsin treatment after incubation
with mitochondria, implying that it was imported into
mitochondria (Figure 5B). Dissipating the membrane po-
tential with the chemical uncoupler FCCP blocks
energy-dependent import of mitochondrial proteins, and
the addition of FCCP reduced the amount of b-actin
surviving trypsin treatment to <1% of the total
(Figure 5B), as was the case for TFAM (data not
shown). Thus, the uptake of b-actin by isolated
mitochondria is largely dependent on the mitochondria
maintaining an electrochemical gradient across the
IMM. Although actin is best known for its cytoskeletal
functions in the cytoplasm it also contributes to several
essential processes in the cell nucleus, including chromatin
remodelling and transcription (26). Nuclear actin works in
conjunction with actin-binding proteins, rather than
binding to DNA directly, and so we envisage a similar
situation in mitochondria.
Co-enrichment of b-actin and NM-IIA with rat liver
mtDNA (Figure 1), and co-fractionation of the same
two proteins with human mtDNA, after protease-
digestion of extra-mitochondrial protein (Figure 5A),
combined with the membrane-potential dependent
import of b-actin into isolated mitochondria (Figure 5B)
suggests that a fraction of these proteins is located inside
mitochondria, associated with mtDNA, where they may
well form a microﬁlament. Bacteria were long believed to
lack a cytoskeleton, yet there is now concrete evidence
they possess structural and functional homologues of the
eukaryotic cytoskeletal proteins actin and tubulin (27).
Given the mitochondrion’s prokaryotic origins, it is
highly plausible that they too have a superstructure or
‘mitoskeleton’, to support the mitochondrial nucleoid,
Figure 3. Loss of MYH10 is associated with mtDNA depletion and changes in mtDNA organization and mitochondrial morphology in mouse
embryonic ﬁbroblasts. (A) DNA was harvested from control (MYH10
+/+) and MYH10
 /  MEFs and mtDNA copy number estimated by Southern
blotting with probes speciﬁc for mtDNA and nuclear DNA (n=3 independent experiments). (B) the distribution of mitochondria was classiﬁed as
one of three types based on visual inspection; the mitochondria of most control cells (NM-IIB
+/B
+) formed an extensive ‘network’ extending to the
cell’s periphery; however in some cells the mitochondria were concentrated close to the nucleus (contracted), in still other cells the mitochondria were
widely distributed but discontinuous, or fragmented. Approximately 80 MYH10
+/+ cells and 80 MYH10
 /  cells were screened and assigned to one
of the three categories. (C) MEF MYH10 +/+ and MYH10
 /  cells labelled with anti-NM-IIB, the mitochondrial speciﬁc stain, mitotracker or
anti-DNA antibody. The antibody to NM-IIB weakly cross-reacted with a nuclear protein, which was only visible when NM-IIB was absent. (D)
Nucleoid number and area were determined in 10 cells per mitochondrial phenotype.
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intra-mitochondrial actomyosin association with mito-
chondrial nucleoids (Figure 6) does not exclude a role
for cytoplasmic actomyosin in mtDNA maintenance.
Based on the results reported here, perturbation of both
b-actin and MYH9/10 expression can cause mtDNA copy
to increase or decrease, dependent on the duration and
extent of the perturbation (Figures 3 and 4,
Supplementary Figures S2 and S4). Thus, we conclude
the proteins have an organizational and structural role
in mtDNA maintenance and are not themselves regulating
mtDNA copy number. Temporal studies of the expression
of other mitochondrial nucleoid proteins, in response to
b-actin or MYH9/10 siRNA could help to clarify how cells
adapt to a dearth of these proteins, and thereby explain
the ﬂuctuations in mtDNA copy number. The changes in
mitochondrial nucleoids and mitochondrial morphology
that accompany decreased expression of MYH9 and
b-actin genes, and ablation of MYH10 (Figures 2–4),
coupled with the physical association of the NM-IIA
and b-actin proteins with mtDNA (Figures 1 and 5) are
all consistent with the hypothesis that actomyosin ﬁla-
ments offer structural support to the mitochondrial
network and mtDNA in mammalian cells. Perturbation
of the cytoskeleton could indirectly affect mtDNA, in
the same way that disruption or mutation of various
proteins required for normal mitochondrial morphology
and movement can affect mtDNA stability, e.g. (28), and
Figure 4. b-Actin siRNA perturbs mtDNA mass, organization and mitochondrial morphology. (A) HOS cell DNA was analysed by Q-PCR at
intervals after transfection of cells with an siRNA targeting b-actin. A 40% decrease in mtDNA copy number was observed 48 72 and 96h after
transfection, which was statistically signiﬁcant only at the 96h time point (P=0.0087); however, when results for the three time points were
combined, the consistent decrease in mtDNA copy number was highly signiﬁcant (***P<0.001). Mitochondrial DNA copy number was highest
144h after transfection; the difference from mock transfected cells just achieved signiﬁcance (*P<0.05), whereas it was more marked compared to
the 96h time point (***P<0.001). (B) immunocytochemistry with an antibody to b-actin indicated that siRNA was effective at repressing b-actin
expression for up to 144h, and this was associated with ‘contraction’ of mitochondria away from the peripheral parts of the cell, and with
mitochondrial fragmentation. (C) after mock transfection or b-actin RNAi, a minimum of 80 cells were scored as having normal (network),
contracted or fragmented mitochondria, at each time point. (D) the number and size (area) of mitochondrial nucleoids were determined in 10
cells for each mitochondrial phenotype. The network phenotypes were obtained from mock-transfected cells, whereas cells with contracted or
fragmented mitochondria were from cells subjected to b-actin RNAi.
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spective contributions of intra- and extra-mitochondrial
b-actin and NM-IIA/B to mtDNA maintenance. This
will be all the more difﬁcult as mitochondrial import of
b-actin appears to be stochastic (Figure 5B), and not de-
pendent on a dedicated mitochondrial form of the protein.
Given the well-recognized role of myosin family
proteins in movement, NM-IIA and IIB are strong candi-
dates for playing a key role in mtDNA segregation or
transmission. Other nucleoid proteins such as ATAD3,
may also form part of the mtDNA segregation apparatus
(29) as well as contributing to mtDNA packaging
(Figure 6).
NM-IIA/B and human disease
Pathological mutations in MYH9 cause hearing loss,
kidney dysfunction and haemopoietic disorders in
humans (30), clinical features that are common to many
mitochondrial disorders (31). In light of this report,
impaired mtDNA homeostasis may account for one or
more of the clinical features associated with known, or
as yet to be described, mutations in MYH9. In particular,
a mitochondrial (DNA) contribution to hearing impair-
ment should be considered because much of the NM-IIA
of cochlear hair cells is located in the mitochondrial
inner membrane, based on immuno-gold electron
microscopy (32).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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